FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileLatigo Biotherapeutics Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LTGO
Latigo Biotherapeutics Inc. Stock AnalysisComprehensive stock analysis for Latigo Biotherapeutics Inc. (LTGO) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisLTGO
LTGO
Latigo Biotherapeutics Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LTGO
  1. Home
  2. Stocks
  3. Latigo Biotherapeutics Inc.
LT

Latigo Biotherapeutics Inc.

🇺🇸LTGO•NASDAQ
LT

Latigo Biotherapeutics Inc.

🇺🇸LTGO•NASDAQ
Market cap
$781.99M

Your view on LTGO

Mkt Cap
$781.99M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Latigo Biotherapeutics Inc.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Nima Farzan
Headquarters
1300 Rancho Conejo Boulevard, Suite 305, Thousand Oak, CA, US
Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Nima Farzan
Headquarters
1300 Rancho Conejo Boulevard, Suite 305, Thousand Oak, CA, US
Description

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418.

The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Latigo Biotherapeutics Inc.. Starting points for Latigo Biotherapeutics Inc.: EPS -$2.84 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Latigo Biotherapeutics Inc.. Trailing twelve-month EPS for Latigo Biotherapeutics Inc. stands at -$2.84. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Latigo Biotherapeutics Inc.. Latigo Biotherapeutics Inc. has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold LTGO12 companies
More Medical - Pharmaceuticals companies
TickerTypeCompanySectorExchangeMkt cap
ORXOYOrexo AB (publ)HealthcareOTC$102.7M
OVITOncoVista Innovative Therapies, Inc.HealthcareOTC$2,356
OXIHFOxford Investments Holdings Inc.HealthcareOTC$71,958
PAVSParanovus Entertainment Technology Ltd.HealthcareNASDAQ$2.0M
PBHPrestige Consumer Healthcare Inc.HealthcareNYSE$2.4B
PKBFFPeakBirch Commerce Inc.HealthcareOTC$544.7M
PLWYPeoplesway.com Inc.HealthcareOTC$1,508
PNDHFPond Technologies Holdings Inc.HealthcareOTC$684,738
PNPLPineapple, Inc.HealthcareOTC$5.6M
POMPOMDOCTOR LtdHealthcareNASDAQ$14.6M
PRPHProPhase Labs, Inc.HealthcareNASDAQ$331,590
PXYNPraxsyn CorporationHealthcareOTC$6,347
Ownership & News

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Latigo Biotherapeutics Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Latigo Biotherapeutics Inc.. Coverage tracks Latigo Biotherapeutics Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Latigo Biotherapeutics Inc.

LTGO AnalysisFair
Past
1
Growth
2
Health
5
Profit
1
Value
1